Results · Apr-Jun 2026
Trident Texofab Q1 FY27 results
Sales fell 7% to ₹26.1 crore from ₹28.1 crore in Apr-Jun 2025.
Operating profit fell 31% to ₹1.4 crore, an operating margin of 5.5% (down 1.9 points from a year ago).
Net profit fell 49% to ₹0.52 crore from ₹1 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −22%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 26.1 | 28.1 | −7% |
| Operating profit (EBITDA) | 1.4 | 2.1 | −31% |
| Operating margin | 5.5% | 7.4% | −1.9 pts |
| Net profit | 0.5 | 1.0 | −49% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.